Our Skills & Expertise

OncoLab brings together cutting-edge innovations with leading scientific expertise and management to take on one of the world’s most challenging  diseases - cancer.

The OncoLab team combines profound knowledge and expertise in tumour biology, oncology and international research projects. Besides the high scientific quality, the CEO of OncoLab has long-term experience in managing and operating diagnostics enterprises as well as in developing and marketing diagnostic tests.


Robert Zeillinger, PhD

Founder and CEO of OncoLab Diagnostics. He also holds a lead­ing posi­tion at the Med­ical Uni­ver­sity of Vienna, Aus­tria, as head of the Mol­e­c­u­lar Oncol­ogy Group at the Depart­ment for Obstet­rics and Gynae­col­ogy. In 1989, he co-​founded Vien­naLab Diag­nos­tics GmbH, an in vitro diag­nos­tics com­pany based in Vienna, Aus­tria, which he suc­cess­fully led until 2010, dri­ving the company’s focus to the com­mer­cial­i­sa­tion of promis­ing diag­nos­tic tests.
Being active for more than 30 years in both aca­d­e­mic and indus­trial research, he is a renowned sci­en­tist and proven leader of inter­dis­ci­pli­nary, multi­na­tional teams. His dis­tin­guished sci­en­tific exper­tise is com­ple­mented by exten­sive expe­ri­ence in coor­di­nat­ing research projects of the EC-​framework pro­grammes FP6 and FP7. He is author and co-​author of more than 200 sci­en­tific pub­li­ca­tions and holds sev­eral patents.

Elisabeth Maritschnegg, PhD

Post­doc­toral fel­low. Elisabeth has received her Master's degree in Molecular Microbiology from the University of Graz, Austria. In the course of her doctroal thesis she substantially contributed to the development and evaluation of a innovative diagnostic approach based on a lavage of the uterine cavity - resulting in the LAVAGE Test. This also included several international multicenter studies. Currently she is participating in several international projects where she analyses different cancer biomarkers. She is experienced in working with circulating tumor cells, circulating DNA, as well as different aspects of the p53 protein.


Gabriele Klaming, MA

COO of Onco­Lab Diag­nos­tics. She holds a Master’s degree in Trans­la­tion Stud­ies from the Uni­ver­sity of Graz, Aus­tria and a Master’s degree in Applied Knowl­edge Man­age­ment from the Uni­ver­sity of Applied Sci­ences in Eisen­stadt, Aus­tria. She has worked in legal lan­guage ser­vices for about ten years and has exten­sive expe­ri­ence in inter­na­tional project man­age­ment and knowl­edge management.


Christa Zeillinger, PhD

Christa Zeillinger is a Biologist and has long­stand­ing expe­ri­ence in diag­nos­tic test kit pro­duc­tion and qual­ity con­trol and assur­ance. Cur­rently, she is in charge of book­keep­ing at Onco­Lab Diag­nos­tics GmbH.


OncoLab Diagnostics GmbH
Hebbelplatz 5
1100 Vienna

© OncoLab Diagnostics GmbH, 2017